News MS Society Canada Urges Parliamentarians to Improve MS Clinics MS Society Canada Urges Parliamentarians to Improve MS Clinics by Patricia Silva, PhD | October 24, 2014 Share this article: Share article via email Copy article link While Canada is home to one of the world’s most comprehensive social healthcare systems, it is unfortunately home to one of the largestĀ multiple sclerosisĀ patient populations as well. According to the Multiple Sclerosis Society of Canada, at least 100,000 Canadians have the disease, and at least 20,000 of them live in the province of Quebec alone. Louis Adam, the society’s Executive Director, said drawing more attention and support to this disease should start with further educating the country’s officials and lawmakers. Earlier this month on October 9th, the MS Society presented 3 priority briefings to the National Assembly. These covered currently available healthcare services for patients with MS, such as: Funding for MS clinics, which are at present quite limited Potential housing options for largely dependent adult patients Public access to available treatments MS Society spokespersonĀ Jocelyne CazinĀ explained that multiple sclerosis is currently one of the more complex neurodegenerative diseases prevalent among adults, and that patients and government officials alike should not settle with allowing symptoms to progress until it necessitates moving disabled patients into facilities. Individuals with MS can still be productive members of society if they receive better treatment in the earlier stages of the disease and are taught proper self-management. [adrotate group=”4″] Quebec’s Ombudsman mentioned in his last annual report that these MS patientsĀ “need flexible service organization that fosters full social participation, which is hard to provide given the organization of care and services in CHSLDs.” Over the past 3 years, several MS clinics in Quebec expressed concern that their currently available treatments and services have become increasingly outdated and limited, and are in threat of further decline in quality because of implemented budget cuts. Dr. Pierre Grammond, a neurologist and the director of the MS clinic at the Centre deĀ rĆ©adaptation en dĆ©ficience physique ChaudiĆØre-Appalaches, said countless studies have proven that proper disease management and positive patient outcomes depend on the quality of care rendered in clinics. As a result, the Society has forwarded an urgent request to representatives for the formation of terms of reference on this debilitating disease. These new terms would go a long way in making sure the country’s clinics are operating on reasonable budgets that allow room for expansion of services, treatment accessibility, and improvement of care for those with the disease. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags autoimmune disease, multiple sclerosis, Multiple Sclerosis Society of Canada
April 22, 2024 News by Marisa Wexler, MS AAN 2024: Briumvi found to ease disability in certain MS patients
April 22, 2024 Columns by Desiree Lama Learning to manage cognitive impairment with multiple sclerosis
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Earlier Ocrevus lowers MS progression risk over 10 years